Lakewood-Amedex Biotherapeutics Stock to Reverse Split on Monday, June 22nd (NASDAQ:LABT)

Lakewood-Amedex Biotherapeutics Inc. (NASDAQ:LABT)’s stock is going to reverse split before the market opens on Monday, June 22nd. The 1-10 reverse split was announced on Wednesday, June 17th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, June 19th.

Lakewood-Amedex Biotherapeutics Stock Performance

Shares of LABT traded down $0.15 during mid-day trading on Thursday, reaching $0.45. The company’s stock had a trading volume of 317,250 shares, compared to its average volume of 2,695,970. Lakewood-Amedex Biotherapeutics has a 52 week low of $0.42 and a 52 week high of $9.82.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen downgraded shares of Lakewood-Amedex Biotherapeutics from a “hold” rating to a “sell” rating in a research note on Saturday, May 30th.

About Lakewood-Amedex Biotherapeutics

We are a biotechnology company focused on leveraging unique, pioneering science to address unmet needs in the treatment of infectious diseases, improving patient outcomes, and significantly reducing the threat posed by antibiotic-resistant bacterial strains, including methicillin resistant Staphylococcus aureus (MRSA), vancomycin resistant Enterococci species (VRE), and others. Antimicrobial resistance (AMR) represents a growing global health crisis, being directly responsible for 1.27 million deaths annually and contributing to nearly 5 million deaths worldwide.